chlorambucil has been researched along with Tumor Lysis Syndrome in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosseifi, SG | 1 |
| Vyas, B | 1 |
| Vyas, H | 1 |
| Krishnaswamy, G | 1 |
| Smith, S | 1 |
| Mahajan, A | 1 |
| Nirmal, S | 1 |
| English, MW | 1 |
| Jenney, ME | 1 |
| Lazda, ED | 1 |
1 review available for chlorambucil and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Glucocort | 2009 |
1 other study available for chlorambucil and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Acute tumor lysis syndrome in Hodgkin disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chlorambucil; Hodgk | 2002 |